Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Kamada (KMDA) Drug Pipeline

16 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Kamada Anti-Sars-Cov-2COVID19, Pneumonia, Viralphase1AndPhase2CompletedSafety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19Sep 10, 2020―
Alpha 1-AntitrypsinAlpha 1-Antitrypsin DeficiencyPhase IIIRecruitingPhase III, Efficacy and Safety of "Kamada-AAT for Inhalation"Dec 17, 2019
Glassia, Methylprednisolone Or Equivalent Steroid, AlbuminGraft Versus Host Diseasephase2AndPhase3TerminatedA Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHDOct 24, 2016―
Kamrab - HrigRabiesPhase IIICompletedPost-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to RabiesSep 18, 2016―
Glassia® And Institution Standard Of Care (Soc)Transplantation, Lung RejectionPhase IICompletedStudy to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung TransplantationNov 15, 2015―
Active Rabies Vaccine (Us-Fda Approved)Rabiesphase2AndPhase3CompletedPhase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy SubjectsNov 28, 2013―
Alpha-1 AntitrypsinNew Onset Type-1 DiabetesPhase IICompletedPhase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 DiabetesNov 27, 2013―
Kamada-Aat For Inhalation, 80Mg, Kamada-Aat For Inhalation, 160MgAlpha-1 Antitrypsin DeficiencyPhase IICompletedPhase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"Nov 24, 2013―
Alpha-1 Antitrypsin 40Mg (Aat, Glassia®), Alpha-1 Antitrypsin 60Mg (Aat, Glassia®), Alpha-1 Antitrypsin 80Mg (Aat, Glassia®)Type 1 Diabetes Mellitusphase1AndPhase2CompletedStudy of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes MellitusFeb 24, 2011―
Kamada Aat For InhalationEmphysemaphase2AndPhase3CompletedInternational Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With EmphysemaSep 15, 2010―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kamada Ltd (IL:KMDA) have in its pipeline
Kamada IL:KMDA is currently developing the following drugs: Kamada Anti-Sars-Cov-2, Alpha 1-Antitrypsin, Glassia, Methylprednisolone Or Equivalent Steroid, Albumin, Kamrab - Hrig, Glassia® And Institution Standard Of Care (Soc), Active Rabies Vaccine (Us-Fda Approved), Alpha-1 Antitrypsin, Kamada-Aat For Inhalation, 80Mg, Kamada-Aat For Inhalation, 160Mg, Alpha-1 Antitrypsin 40Mg (Aat, Glassia®), Alpha-1 Antitrypsin 60Mg (Aat, Glassia®), Alpha-1 Antitrypsin 80Mg (Aat, Glassia®), Kamada Aat For Inhalation, Aerosolized, Human, Plasma-Derived Alpha-1 Antitrypsin. These drug candidates are in various stages of clinical development as the company works toward FDA approval.